Dapagliflozin Use in Heart Failure with Reduced Ejection Fraction Accompanied by Type 2 Diabetes Mellitus: A Systematic Review

Abstract: Heart failure patients with reduced ejection fraction (HFrEF) respond well to pharmacological therapy and show a better prognosis. Heart failure patients with reduced ejection fraction and type 2 diabetes who were given SGLT-2 inhibitor therapy showed a strong and consistent reduction in t...

Full description

Saved in:
Bibliographic Details
Main Authors: Sinta Dwi Juniar, -, Budi Susetyo Pikir, -, Mochamad Yusuf Alsagaff, -, Pudji Lestari, -
Format: Article PeerReviewed
Language:English
English
English
Published: Universitas Airlangga 2022
Subjects:
Online Access:https://repository.unair.ac.id/126361/1/30.%20Dapagliflozin%20Use%20in%20Heart%20Failure%20with%20Ejection%20Fraction%20Accompanied%20by%20Type%202%20Diabetes%20Mellitus%20A%20Systematic%20Review_CCJ%202021.pdf
https://repository.unair.ac.id/126361/2/karil%2030.pdf
https://repository.unair.ac.id/126361/3/30.%20Turnitin.pdf
https://repository.unair.ac.id/126361/
https://e-journal.unair.ac.id/CCJ/article/view/32358
https://doi.org/10.20473/ccj.v3i1.2022.60-74
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Universitas Airlangga
Language: English
English
English